Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I don't have PM but did reciprocate
With that being said, I will also give LG a call tomorrow. I would also like to understand the terms of the $17.5 conversion a little better.
God willing...NWBO will help in saving many lives!!
I actually agree with aspects of what you are saying Steppenwolf. Have you considered calling Les Goldman (he is actually quite responsive on answering his cell phone) and asking him these very questions? You have every right as a shareholder to do this and demand some answers.
Per my conversation with LG after ASCO he specifically stated that their intent was to get the attraction of the medical community and big pharma. I firmly believe in their science but to date their PR is in dire need of assistance.
With that being said, I still continue to accumulate shares especially at these levels
In case you don't have it, LG's cell phone is 202-841-7909
Some big buys at $4.30 is right!!! GLTA
Great layout of the facts and AF's obvious agenda here. It is still beyond me how he is able to have such an affect of the pps of NWBO with his faulty, meaningless articles??
His track record has been blemished as of recent and will be again quite soon!
Eval-
This is specifically what was posted:
Question posed on YMB:
Does anyone know if the prescribing DOCTOR has to hold a PERSONAL LIABILITY with the patient under the GERMANY HE protocol?
I can't imagine this would be the case and I haven't investigated it yet but thought I would toss it out there for some feedback.
TIA..HWY
I would say that puts things into perspective! Great post Senti
So ready for it...my biotech's have taken a beating!
U noticed that too Maybe we can convince him to stay quiet for a week or so! GLTA
rrfly-
I have been all over trying to get my friend on the horn to discuss what he found out. I did finally talk with him this afternoon. He was stuck in another meeting at the time of the NWBO meeting so he had his business partner do the meeting. Here is my disclaimer before I move forward:
My friend founded an investment firm which mainly invests in Biotech. He shorts many of his positions as well as takes long positions. He was a research analyst for a CA hedge fund and prior to that he was with an investment banking group. All in all he has a ton of experience and most of it with Biotech.
He knows my position with NWBO so I have been asking him to look into them for a while and I know he wouldn't BS me.
Based on his partners meeting with NWBO he told me to be very cautious. Apparently his partner met with LP and LG. LG did most of the talking but from what he said, "they were very defensive the whole time and not forthcoming with any specifics." Nothing new here given the attacks they have been under as well as some of the line of questioning simply might have been topics that they aren't allowed to discuss. He agreed with me on this so that settled my nerves a little. That being said, none of the questions I sent him were able to be answered.
His partner went into their financing and the recent $17.5M deal. He states they got very uncomfortable talking about their financing and wanted to talk more about the PIM announcement. He also said that most of the institutional involvement in NWBO is with groups that typical "short" a companies stock and don't hold a longterm investment. He did say it was a vote of confidence to have Franklin owning roughly $1M shares.
All in all I got nothing significant out of the conversation. I think was the data is out, it will speak for itself and we will see the big boys come onboard. I remain very confident in NWBO I just wish they actually had someone to handle their PR properly!!
I sold about 4k of my shares at ~7.95 (good profit from 4.91 large buy) and then started buying back at 6.06 all the way down to where we are at today.
I have not had any feedback from the two Seattle news sources I emailed and of course nothing back yet from Dr. Siegel. I as many will continue to contribute the best way I can. GLTA
New article our by SA, "Update: Northwest Biotherapeutics Stock In Turmoil, But Not For Long"
Good ole Trevor Lowenthal
Lifestyles of the rich and not so famous...all while sitting is the basement of his parents house Poor tick, a big ole yacht and no one to play with
Could be but I really think this and has always been (since the initial big run up beginning of the year)a heavily manipulated stock. Money is being made hand over fist on both ends by the MM's and the best thing you can do is know your own strategy and don't get emotional over this blatant BS
YEP!!! Where's da ticker btw?? Hope to mid 6's within 1-2 weeks
I know! I have 6K shares below 4.78..bout time to turn this thing around!! GLTU
Massive naked shorting...they win on both ends of the deal given very good news right around the corner (hopefully)
Every time I buy thinking it's bottomed out it keeps heading south. Oh well...our day is coming!!
Anyone know if Xena and Maverick have checked out?
Sitting on 6K shares ranging from 4.27 today but most purchased at 4.77 and the high being 5.22. Gonna be a good ride when this starts to rip!
Sounds like someone needs to get back on that red wine asap...more logical thinking seemed to be happening then
Bitter?
Just saw this on the news headlines and plan on sending NWBO's info to him. See story below
http://www.newser.com/story/195858/tv-anchor-i-have-just-months-to-live.html?utm_source=part&utm_medium=united&utm_campaign=rss_topnews
Absolutely!! FYI, my contact that had the interview with NWBO is an analyst!! I will fill you in when I hear from him
On the road today but will update everyone if we get any answers to questions from meeting with NWBO today.
Thanks for all the input on the letter to Dr. Siegel, keep your fingers crossed!!
I will definitely follow up with Dr. Siegel with a phone call! Thnx for passing that # along. I will also send the email to Dr. Sanjay Gupta.
Email just went out to Dr Siegel as well as 2 news stations in Seattle!
How bout we call it the FliPyrr Party
Hah...No prob as long as I get to enjoy it as well Great to see you still on board Steven!!!
I still would like to hear from a few more of you if possible before I send this out to Dr. Siegel
Thank you Sir!
Thank you for ALL of your work. I can assure you that US posters would be more than happy to spread the good news I just wanted to be sensitive to Allan and the exposure.
Look at this full on "desperation mode" going on...da picker
Thnx for all your efforts!!
Flip,
Maybe your amazing sleuthing should also make its way to Melanie Sloan/CREW??
Have you put your findings out there on any other sites yet?
Dang...I can't imagine being your wife Thanks for your input but I do think the email needs to contain substance and I certainly gave it quite the haircut. Will wait for more input before I fire it off
DoGodd,
Not that Allan wants his story to be front and center on various media outlets but do you know if he minds others sharing his story? TIA
Tried to condense with better "flow." I would like to get this out asap so pls continue to shred at will Once again, I have not added any of the attacks they have sustained but I certainly can?
Dr. Siegel,
I wanted to bring to your attention a clinical trial cancer therapy that you showcased on Fox News back in November 2013 titled, “Could our own bodies hold the key to curing cancer.” The company I am referring to is Northwest Biotherapeutics (NWBO) and their cancer vaccine is DCVax. The highlight of this piece was showcasing DCVax L which is used in the treatment of Glioblastoma Multiforme. There have been many exciting developments since then that I would like to share with you.
In March of 2014 NWBO announced that it had received “early access” Hospital Exemption (HE) from the German FDA for treatment of any glioma brain cancer. This is quite significant in the following key ways:
• the first immunotherapy;
• the first product which exerts pharmacological (i.e., drug-like) effects in the patient's body;
• the first product that has never previously been on the market commercially;
• the first product developed by a non-German company, not previously under the German regulators' oversight; and
• the first "somatic" cell therapy product (a somatic cell is any cell of the body other than a reproductive or embryonic cell).
In addition to obtaining HE, the German reimbursement authority has approved DCVaxL treatment for reimbursement from health insurers. To date, 10 Hospitals have applied for reimbursement status. This eligibility is quite rare given they are still in clinical trials.
NWBO’s second platform drug/vaccine is DCVax Direct. The Phase I/II trial of DCVax-Direct is treating patients with advanced, inoperable cancers involving multiple metastases (including metastatic colon cancer, pancreatic cancer, sarcoma, melanoma and others). Although these patients have such advanced metastatic disease, only one tumor is being injected in each patient because the current trial is a first-in-man study. This clinical trial includes a total of 60 patients: 36 in the Phase I (safety) portion and 24 in the Phase II (efficacy) portion. The DCVax-Direct trial began treating its first patients in Q3 of last year.
To date, 23 out of the 36 patients enrolled are undergoing treatments. The remaining 13 patients just started treatments in June. Now to the exciting early responses being seen:
• 13 of the 20 patients who have completed at least 3 of the 6 total treatments have shown early signs of tumor cell death, tumor shrinkage and/or stoppage of the progression of their disease
• 9 of these patients have completed 4 of the 6 treatments
• All 9 or 100% of these patients are showing positive early response of tumor cell death, shrinkage and/or stoppage of the progression of their disease
• In 3 of the 9 patients, biopsies currently show NO live tumor cells
Keep in mind that these patients have run out of treatment options and are essentially on the doorstep of Hospice Care.
Finally I would like to share two amazing stories from patients who underwent treatment in this DCVax Direct trial:
The first remarkable story was recently showcased on the charity fundraiser Stand Up 2 Cancer. The patient is Allan Butler who is the VP of the National Geographic Channel. Allan was diagnosed with Stage 4 Pancreatic Cancer and after 4 months of unsuccessful Chemotherapy he was told that there were no other treatment options left. Below is the link to the clip of Allan’s story.
http://channel.nationalgeographic.com/channel/videos/national-geographic-stands-up-to-cancer/
Allan is now 18 months post diagnosis and feeling great. This is truly remarkable given clinical studies show that 50% of such stage 4 pancreatic patients die within six months and 77% within one year. Perhaps as few as 2-3% survive beyond 18 months.
The last truly remarkable story out of this trial is involves a sarcoma patient with a large tumor mass and multiple inoperable metastatic tumors in the lung. This patient received the first 3 DCVax-Direct injections through the course of a month, starting in February. He received a fourth injection in early April and then was scanned for results in early May. At that time, this patient’s MRI scan showed extensive necrosis and partial collapse of the injected large tumor mass, and a CT scan showed some early indication of shrinkage of one of the non-injected metastasized tumors. These results suggest both local and systemic effects of the DCVax-Direct treatment, as were seen in the pre-clinical studies.
These encouraging results were further supported by tumor biopsies taken at the time of the most recent injection, which showed a high rate of tumor necrosis and appearance of T cells (immune cells) infiltrating into the injected tumor.
Given that Northwest Biotherapeutics is a small cap biotech company, they have literally been exhausting all resources with their trials, German price negotiations, setting up manufacturing infrastructure in Europe etc… What has been lacking is exposure by any media coverage here in the US. I am hoping you will once again take some time to contact this Company as well as Allan Butler and share this potential cancer treatment game changer.
Kind Regards,
Scott Hammons